DSIP
Circadian Research Research · 5mg
Size: 5mg
With code SPOOKY
35% off sitewide with code SPOOKY — apply it in your cart
DSIP (delta sleep-inducing peptide) is a nine-amino-acid neuropeptide first isolated during slow-wave sleep research. This compound is supplied lyophilized for laboratory preparation of solutions used in preclinical investigations of sleep architecture, circadian regulation and stress-response signaling pathways.
For Research Purposes Only.
Research Use Notes
Supplied as lyophilized powder
Requires reconstitution before use
Research Water required for mixing (sold separately)
Swirl gently, never shake
Storage
Store lyophilized powder vial in freezer
Keep at 2 to 8°C
Protect from light and heat
After mixing, keep refrigerated
Use within typical research handling window after reconstitution
Handling
Use sterile technique during reconstitution
For laboratory research use only
Certificate of Analysis
Every batch is independently third-party tested before it ships.
- Strength
- 5MG
- Form
- Lyophilized powder
- Testing
- Third-party, batch-specific
All certificates are issued by independent ISO-accredited laboratories. Lot-specific documents are made available to qualified research professionals on request.
Frequently Bought Together
Commonly paired to support consistent, reliable experimentation.
Compound Information
Technical specifications
What Is DSIP?
Circadian Research Research · 5mg
- SKU
- 021
- Category
- Circadian Research, Compounds
- Strength
- 5MG
- Also known as
- Delta sleep-inducing peptide · WAGGDASGE
- Type
- Synthetic nonapeptide
- CAS Number
- 62568-57-4
- Molecular Weight
- 848.8 g/mol
- Form
- Lyophilized powder
- Sizes
- 5mg
Stability Information
-20°C
24+ months
2-8°C
~30 days
Products are intended solely for laboratory and scientific research purposes. Not intended for human consumption, veterinary use, diagnosis, treatment, cure, or prevention of disease.
All the research compounds you need, with the confidence that every batch is 7× tested before it ships.
Subscribe to our Newsletter
Subscribe to our newsletter to get daily insights, news, updates.